Group by: Item Type | Date | No Grouping
Number of items: 10.

Cabarrou, BastienIdRef, Leconte, EveIdRef, Sfumato, Patrick, Boher, Jean-MarieIdRef and Filleron, ThomasIdRef (2022) A stratified adaptive two-stage design with co-primary endpoints for phase II clinical oncology trials. BMC Medical Research Methodology, vol. 22 (n° 278).

Somda, SergeIdRef, Ouedraogo, Yacouba, Dabone, Eric, Leconte, EveIdRef and Filleron, ThomasIdRef (2021) Assessing the sensitivity of the Kaplan-Meier confidence interval according to the median follow-up. JP Journal of Biostatistics, vol. 18 (n° 1). pp. 67-85.

Gilhodes, J., Dalenc, FlorenceIdRef, Gal, JocelynIdRef, Zemmour, C., Leconte, EveIdRef, Boher, Jean-MarieIdRef and Filleron, ThomasIdRef (2020) Comparison of Variable Selection Methods for Time-to-Event Data in High-Dimensional Settings. Computational and Mathematical Methods in Medecine, 2020 (6795392). 13 pages-13 pages.

Cabarrou, BastienIdRef, Dalenc, FlorenceIdRef, Leconte, EveIdRef, Boher, Jean-MarieIdRef and Filleron, ThomasIdRef (2018) Focus on an infrequently used quantity in the context of competing risks : The conditional probability function. Computers in Biology and Medicine, vol. 101. pp. 70-81.

Gilhodes, J., Zemmour, C., Ajana, S., Martinez, A., Delord, Jean-Pierre, Leconte, EveIdRef, Boher, Jean-MarieIdRef and Filleron, ThomasIdRef (2017) Comparison of variable selection methods for high-dimensional survival data with competing events. Computers in Biology and Medicine, 91 (1). pp. 159-167.

Cabarrou, BastienIdRef, Sfumato, Patrick, Mourey, Loïc, Leconte, EveIdRef, Balardy, Laurent, Delord, Jean-Pierre, Boher, Jean-MarieIdRef and Filleron, ThomasIdRef (2017) Comment prendre en compte l’hétérogénéité dans le schéma des essais cliniques de phase II en oncogériatrie ? Revue d'Epidémiologie et de Santé Publique, 65 (Supplément). S60-S60.

Somda, SergeIdRef, Culine, StéphaneIdRef, Chevreau, Christine, Fizazi, KarimIdRef, Leconte, EveIdRef, Kramar, AndrewIdRef and Filleron, ThomasIdRef (2017) A Statistical Approach to Determine the Optimal Duration of Post-Treatment Follow-Up: Application to Metastatic Nonseminomatous Germ Cell Tumors. Clinical Genitourinary Cancer, 15 (2). pp. 230-236.

Asselain, BernardIdRef, Boher, Jean-MarieIdRef, Filleron, ThomasIdRef, Kramar, AndrewIdRef, Leconte, EveIdRef and Somda, SergeIdRef (2016) Optimal scheduling of post-therapeutic follow-up of patients treated for cancer for early detection of relapses. Statistical Methods in Medical Research, 25 (n°6). pp. 2457-2471.

Filleron, ThomasIdRef, Florence, D., Leconte, EveIdRef and Somda, SergeIdRef (2016) Oncologic surveillance after curative treatment: A probability-based approach should be preferred to a risk-based approach. Urological Oncology: Seminars and Original Investigations, 34 (5). pp. 244-245.

Chevreau, Christine, Delannes, MartineIdRef, Filleron, ThomasIdRef, Kramar, AndrewIdRef, Leconte, EveIdRef, Penel, Nicolas, Rios, M.IdRef and Somda, SergeIdRef (2014) Determining the Length of Posttherapeutic Follow-up for Cancer Patients Using Competing Risks Modeling. Medical Decision Making, vol.34 (n°2). pp. 168-79.

This list was generated on Sat Apr 19 03:20:44 2025 CEST.